MRK
Merck & Co., Inc.$110.50+0.28 (+0.25%)Prev Close$110.23·MCap$289.58B·P/E15.18·Vol2.70M·Yield0.03%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
17
$33.04M
◆
Net Activity
Net Seller
$33.04M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Merck & Co., Inc. (MRK) has been exclusively selling, with 0 insider purchases totaling $0.00 and 17 insider sales totaling $33.04M. The most recent insider transaction was by Guindo Chirfi (officer: Chief Marketing Officer), who sold $1.21M worth of shares on Feb 12, 2026. Merck & Co., Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $289.58B.
MRK Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Guindo Chirfi | officer: Chief Marketing Officer | Sell | 10,000 | $121.46 | $1.21M | 60,615 |
| Feb 10, 2026 | Li Dean Y | officer: Executive VP & President, MRL | Sell | 10,235 | $117.52 | $1.20M | 92,035 |
| Feb 9, 2026 | Guindo Chirfi | officer: Chief Marketing Officer | Sell | 10,000 | $118.41 | $1.18M | 70,615 |
| Feb 9, 2026 | Zachary Jennifer | officer: EVP, General Counsel | Sell | 38,835 | $119.15 | $4.63M | 68,916-36% |
| Feb 6, 2026 | Davis Robert M | director, officer: Chairman, CEO & President | Sell | 47,434 | $118.04 | $5.60M | 476,064 |
| Feb 6, 2026 | Li Dean Y | officer: Executive VP & President, MRL | Sell | 15,087 | $118.77 | $1.79M | 102,270 |
| Feb 6, 2026 | DeLuca Richard R. | officer: EVP&Pres, Merck Animal Heallth | Sell | 37,685 | $120.92 | $4.56M | 160,174 |
| Feb 6, 2026 | Litchfield Caroline | officer: EVP & CFO | Sell | 41,997 | $119.61 | $5.02M | 90,192-32% |
| Feb 6, 2026 | Guindo Chirfi | officer: Chief Marketing Officer | Sell | 20,000 | $121.88 | $2.44M | 80,615 |
| Feb 6, 2026 | Williams David Michael | officer: EVP,Chief Info&Digital Officer | Sell | 5,000 | $121.91 | $609.5K | 30,838 |
| Feb 6, 2026 | Oosthuizen Johannes Jacobus | officer: President, U.S. Market | Sell | 15,000 | $121.87 | $1.83M | 21,197-41% |
| Feb 6, 2026 | Smart Dalton E. III | officer: SVP Fin. - Global Controller | Sell | 6,400 | $119.68 | $765.9K | 10,605-38% |
| Nov 4, 2025 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 8,614 | $83.59 | $720.0K | 0 |
| Aug 5, 2025 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 8,432 | $79.29 | $668.6K | 0 |
| May 2, 2025 | Smart Dalton E. III | SVP Fin. - Global Controller | Sell | 290 | $84.05 | $24.4K | 0 |
| May 2, 2025 | Larson Betty D | EVP, Chief HR Officer | Sell | 5,153 | $84.71 | $436.5K | 0 |
| Apr 29, 2025 | Smart Dalton E. III | SVP Fin. - Global Controller | Sell | 4,262 | $82.76 | $352.7K | 0 |
| Feb 20, 2025 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 8,500 | $84.09 | $714.7K | 0 |
| Feb 11, 2025 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 6,404 | $87.28 | $558.9K | 0 |
| Feb 7, 2025 | Downing Cristal N | Chief Comm. & Public Afrs Ofcr | Sell | 2,361 | $88.76 | $209.6K | 0 |
| Mar 11, 2024 | Merck & Co., Inc. | Buy | 21,397,205 | $23.00 | $492.14M0.9% OS | 1,000 | |
| Feb 15, 2024 | Davis Robert M | Chairman, CEO & President | Sell | 235,021 | $125.69 | $29.54M | 373,651-39% |
| Feb 15, 2024 | Litchfield Caroline | EVP & CFO | Sell | 38,291 | $125.50 | $4.81M | 50,908-43% |
| Feb 14, 2024 | Romanelli Joseph | President, Human Health Int?l | Sell | 1,000 | $124.89 | $124.9K | 19,569 |
| Feb 12, 2024 | Li Dean Y | Executive VP & President, MRL | Sell | 14,702 | $125.50 | $1.85M | 46,242 |
| Feb 8, 2024 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 1,451 | $127.57 | $185.1K | 19,812 |
| Feb 5, 2024 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 18,959 | $127.17 | $2.41M | 23,327-45% |
| Feb 2, 2024 | Zachary Jennifer | EVP, General Counsel | Sell | 49,499 | $126.97 | $6.28M | 29,058-63% |
| Feb 2, 2024 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 50,694 | $126.65 | $6.42M | 23,619-68% |
| Nov 13, 2023 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 2,081 | $102.38 | $213.1K | 18,191 |
| Nov 9, 2023 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Sell | 43,823 | $105.03 | $4.60M | 111,764-28% |
| Aug 15, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 4,250 | $109.01 | $463.3K | 22,935 |
| Aug 4, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 4,500 | $105.49 | $474.7K | 27,185 |
| Aug 3, 2023 | Romanelli Joseph | President, Human Health Int?l | Sell | 89 | $107.37 | $9.6K | 20,569 |
| Jun 30, 2023 | Romanelli Joseph | President, Human Health Int?l | Buy | 409 | $108.40 | $44.3K | 20,631 |
| Jun 30, 2023 | Romanelli Joseph | President, Human Health Int?l | Sell | 35 | $104.65 | $3.7K | 20,596 |
| May 5, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 53,400 | $119.01 | $6.36M | 60,085-47% |
| May 5, 2023 | Zachary Jennifer | EVP, General Counsel | Sell | 19,141 | $117.59 | $2.25M | 35,128-35% |
| May 5, 2023 | Karachun Rita A | Sr. VP Fince-Global Controller | Sell | 15,875 | $117.53 | $1.87M | 45,710-26% |
| May 3, 2023 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 7,509 | $116.82 | $877.2K | 11,059-40% |
| May 2, 2023 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Sell | 141,599 | $115.55 | $16.36M | 154,493-48% |
| Apr 28, 2023 | Davis Robert M | Chairman, CEO & President | Sell | 143,329 | $114.93 | $16.47M | 271,817-35% |
| Apr 14, 2023 | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Sell | 134,055 | $115.07 | $15.43M | 67,892-66% |
| Feb 16, 2023 | Romanelli Joseph | President, Human Health Int?l | Sell | 5,000 | $108.22 | $541.1K | 20,284 |
| Feb 14, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 1,815 | $109.10 | $198.0K | 33,085 |
| Feb 10, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 5,000 | $107.00 | $535.0K | 34,900 |
| Feb 8, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 4,436 | $104.25 | $462.5K | 39,900 |
| Feb 6, 2023 | Zachary Jennifer | EVP, General Counsel | Sell | 75,436 | $103.17 | $7.78M | 53,920-58% |
| Jan 11, 2023 | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Sell | 83,994 | $112.29 | $9.43M | 77,896-52% |
| Nov 10, 2022 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 1,795 | $103.21 | $185.3K | 16,731 |
Showing 1–50 of 72
1 / 2
MRK Insider Buying Activity
The following table shows recent insider purchases of Merck & Co., Inc. (MRK) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Merck & Co., Inc. | Buy | 21,397,205 | $23.00 | $492.14M0.9% OS | 1,000 | |
| Jun 30, 2023 | Romanelli Joseph | President, Human Health Int?l | Buy | 409 | $108.40 | $44.3K | 20,631 |
MRK Insider Selling Activity
The following table shows recent insider sales of Merck & Co., Inc. (MRK) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Guindo Chirfi | officer: Chief Marketing Officer | Sell | 10,000 | $121.46 | $1.21M | 60,615 |
| Feb 10, 2026 | Li Dean Y | officer: Executive VP & President, MRL | Sell | 10,235 | $117.52 | $1.20M | 92,035 |
| Feb 9, 2026 | Guindo Chirfi | officer: Chief Marketing Officer | Sell | 10,000 | $118.41 | $1.18M | 70,615 |
| Feb 9, 2026 | Zachary Jennifer | officer: EVP, General Counsel | Sell | 38,835 | $119.15 | $4.63M | 68,916-36% |
| Feb 6, 2026 | Davis Robert M | director, officer: Chairman, CEO & President | Sell | 47,434 | $118.04 | $5.60M | 476,064 |
| Feb 6, 2026 | Li Dean Y | officer: Executive VP & President, MRL | Sell | 15,087 | $118.77 | $1.79M | 102,270 |
| Feb 6, 2026 | DeLuca Richard R. | officer: EVP&Pres, Merck Animal Heallth | Sell | 37,685 | $120.92 | $4.56M | 160,174 |
| Feb 6, 2026 | Litchfield Caroline | officer: EVP & CFO | Sell | 41,997 | $119.61 | $5.02M | 90,192-32% |
| Feb 6, 2026 | Guindo Chirfi | officer: Chief Marketing Officer | Sell | 20,000 | $121.88 | $2.44M | 80,615 |
| Feb 6, 2026 | Williams David Michael | officer: EVP,Chief Info&Digital Officer | Sell | 5,000 | $121.91 | $609.5K | 30,838 |
| Feb 6, 2026 | Oosthuizen Johannes Jacobus | officer: President, U.S. Market | Sell | 15,000 | $121.87 | $1.83M | 21,197-41% |
| Feb 6, 2026 | Smart Dalton E. III | officer: SVP Fin. - Global Controller | Sell | 6,400 | $119.68 | $765.9K | 10,605-38% |
| Nov 4, 2025 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 8,614 | $83.59 | $720.0K | 0 |
| Aug 5, 2025 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 8,432 | $79.29 | $668.6K | 0 |
| May 2, 2025 | Smart Dalton E. III | SVP Fin. - Global Controller | Sell | 290 | $84.05 | $24.4K | 0 |
| May 2, 2025 | Larson Betty D | EVP, Chief HR Officer | Sell | 5,153 | $84.71 | $436.5K | 0 |
| Apr 29, 2025 | Smart Dalton E. III | SVP Fin. - Global Controller | Sell | 4,262 | $82.76 | $352.7K | 0 |
| Feb 20, 2025 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 8,500 | $84.09 | $714.7K | 0 |
| Feb 11, 2025 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 6,404 | $87.28 | $558.9K | 0 |
| Feb 7, 2025 | Downing Cristal N | Chief Comm. & Public Afrs Ofcr | Sell | 2,361 | $88.76 | $209.6K | 0 |
| Feb 15, 2024 | Davis Robert M | Chairman, CEO & President | Sell | 235,021 | $125.69 | $29.54M | 373,651-39% |
| Feb 15, 2024 | Litchfield Caroline | EVP & CFO | Sell | 38,291 | $125.50 | $4.81M | 50,908-43% |
| Feb 14, 2024 | Romanelli Joseph | President, Human Health Int?l | Sell | 1,000 | $124.89 | $124.9K | 19,569 |
| Feb 12, 2024 | Li Dean Y | Executive VP & President, MRL | Sell | 14,702 | $125.50 | $1.85M | 46,242 |
| Feb 8, 2024 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 1,451 | $127.57 | $185.1K | 19,812 |
| Feb 5, 2024 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 18,959 | $127.17 | $2.41M | 23,327-45% |
| Feb 2, 2024 | Zachary Jennifer | EVP, General Counsel | Sell | 49,499 | $126.97 | $6.28M | 29,058-63% |
| Feb 2, 2024 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 50,694 | $126.65 | $6.42M | 23,619-68% |
| Nov 13, 2023 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 2,081 | $102.38 | $213.1K | 18,191 |
| Nov 9, 2023 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Sell | 43,823 | $105.03 | $4.60M | 111,764-28% |
| Aug 15, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 4,250 | $109.01 | $463.3K | 22,935 |
| Aug 4, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 4,500 | $105.49 | $474.7K | 27,185 |
| Aug 3, 2023 | Romanelli Joseph | President, Human Health Int?l | Sell | 89 | $107.37 | $9.6K | 20,569 |
| Jun 30, 2023 | Romanelli Joseph | President, Human Health Int?l | Sell | 35 | $104.65 | $3.7K | 20,596 |
| May 5, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 53,400 | $119.01 | $6.36M | 60,085-47% |
| May 5, 2023 | Zachary Jennifer | EVP, General Counsel | Sell | 19,141 | $117.59 | $2.25M | 35,128-35% |
| May 5, 2023 | Karachun Rita A | Sr. VP Fince-Global Controller | Sell | 15,875 | $117.53 | $1.87M | 45,710-26% |
| May 3, 2023 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 7,509 | $116.82 | $877.2K | 11,059-40% |
| May 2, 2023 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Sell | 141,599 | $115.55 | $16.36M | 154,493-48% |
| Apr 28, 2023 | Davis Robert M | Chairman, CEO & President | Sell | 143,329 | $114.93 | $16.47M | 271,817-35% |
| Apr 14, 2023 | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Sell | 134,055 | $115.07 | $15.43M | 67,892-66% |
| Feb 16, 2023 | Romanelli Joseph | President, Human Health Int?l | Sell | 5,000 | $108.22 | $541.1K | 20,284 |
| Feb 14, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 1,815 | $109.10 | $198.0K | 33,085 |
| Feb 10, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 5,000 | $107.00 | $535.0K | 34,900 |
| Feb 8, 2023 | MIZELL STEVEN | EVP, Chief HR Officer | Sell | 4,436 | $104.25 | $462.5K | 39,900 |
| Feb 6, 2023 | Zachary Jennifer | EVP, General Counsel | Sell | 75,436 | $103.17 | $7.78M | 53,920-58% |
| Jan 11, 2023 | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Sell | 83,994 | $112.29 | $9.43M | 77,896-52% |
| Nov 10, 2022 | Oosthuizen Johannes Jacobus | President, U.S. Market | Sell | 1,795 | $103.21 | $185.3K | 16,731 |
MRK Insiders
Similar Stocks to MRK
LLY
Eli Lilly and Company
$864.41-0.44%
$869.14B
JNJ
Johnson & Johnson
$227.08+0.74%
$555.94B
ABBV
AbbVie Inc.
$196.56-0.44%
$360.31B
AMGN
Amgen Inc.
$340.40+0.04%
$188.76B
GILD
Gilead Sciences, Inc.
$128.66+0.73%
$168.65B
PFE
Pfizer Inc.
$26.61-0.65%
$156.54B
BMY
Bristol-Myers Squibb Company
$57.98+0.37%
$120.73B
BIIB
Biogen Inc.
$183.00+1.28%
$26.91B